Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) HKSE
63.50
+3.95(+6.63%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
63.50
+3.95(+6.63%)
Currency In HKD
| Market Cap | 3.18B |
| Enterprise Value | 3.37B |
| P/E Ratio | 167 |
| PEG Ratio | 0.63 |
| Price/Sales Ratio | 18.85 |
| Price/Book Ratio | 24.75 |
| Enterprise/Revenue | 18.96 |
| Enterprise/EBITDA | 59.04 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | 0.11 |
| Operating Margin | 0.22 |
| Return On Assets | 0.05 |
| Return On Equity | 0.15 |
| Revenue | 980.45M |
| Revenue/Share | 3.01 |
| Gross Profit | 761.52M |
| EBITDA | 303.8M |
| Net Income | 33.54M |
| Diluted EPS | 0.08 |
| Total Cash | 486.84M |
| Total Cash/Share | 1.23 |
| Total Debt | 614.18M |
| Total Debt/Equity | 0.69 |
| Current Ratio | 1.89 |
| Book Value Per Share | 2.26 |
| 52-Week Change | 375.3 |
| 52-Week High | 65.05 |
| 52-Week Low | 11.1 |
| Moving Average 50 Days | 51.36 |
| Moving Average 200 Days | 33.43 |
| Average Volume | 1.79M |
| Shares Outstanding | 402.81M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |